Prograf Hart hylki 0,5 mg Islandia - islandés - LYFJASTOFNUN (Icelandic Medicines Agency)

prograf hart hylki 0,5 mg

astellas pharma a/s* - tacrolimusum mónohýdrat - hart hylki - 0,5 mg

Prograf Hart hylki 1 mg Islandia - islandés - LYFJASTOFNUN (Icelandic Medicines Agency)

prograf hart hylki 1 mg

astellas pharma a/s* - tacrolimusum mónohýdrat - hart hylki - 1 mg

Prograf Hart hylki 5 mg Islandia - islandés - LYFJASTOFNUN (Icelandic Medicines Agency)

prograf hart hylki 5 mg

astellas pharma a/s* - tacrolimusum mónohýdrat - hart hylki - 5 mg

Zoloft Filmuhúðuð tafla 100 mg Islandia - islandés - LYFJASTOFNUN (Icelandic Medicines Agency)

zoloft filmuhúðuð tafla 100 mg

upjohn eesv - sertralinum hýdróklóríð - filmuhúðuð tafla - 100 mg

Zoloft Filmuhúðuð tafla 50 mg Islandia - islandés - LYFJASTOFNUN (Icelandic Medicines Agency)

zoloft filmuhúðuð tafla 50 mg

upjohn eesv - sertralinum hýdróklóríð - filmuhúðuð tafla - 50 mg

Lytgobi Unión Europea - islandés - EMA (European Medicines Agency)

lytgobi

taiho pharma netherlands b.v. - futibatinib - cholangiocarcinoma - antineoplastic lyfjum - lytgobi monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic cholangiocarcinoma with a fibroblast growth factor receptor 2 (fgfr2) fusion or rearrangement that have progressed after at least one prior line of systemic therapy.

Nexium Control Unión Europea - islandés - EMA (European Medicines Agency)

nexium control

glaxosmithkline dungarvan limited - esomeprazol - meltingarfærakvilla - róteind dæla hemlar - nexium control er ætlað til skamms tíma meðhöndlunar á bakflæðissjúkdómum (e. brjóstsviða og sýruuppfall) hjá fullorðnum.